Manuel Guzmán

发表

Anticancer mechanisms of cannabinoids.

G. Velasco, M. Guzmán, C. Sánchez, 2016, Current oncology.

Effects of cannabinoids on energy metabolism.

M. Guzmán, C. Sánchez, C. Sánchez, 1999, Life sciences.

Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes.

I. Galve-Roperh, D. Rueda, M. Guzmán, 1998, Molecular pharmacology.

A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme

G. Velasco, I. Galve-Roperh, M. Guzmán, 2006, British Journal of Cancer.

Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.

G. Velasco, M. Guzmán, M. Geelen, 1997, Archives of biochemistry and biophysics.

Inhibition of tumor angiogenesis by cannabinoids

A. Planas, J. Jorcano, J. Aragonés, 2002 .

The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt.

G. Velasco, T. Gómez del Pulgar, M. Guzmán, 2000, The Biochemical journal.

Ceramide: a new second messenger of cannabinoid action.

I. Galve-Roperh, M. Guzmán, C. Sánchez, 2001, Trends in pharmacological sciences.

The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK

G. Velasco, M. Guzmán, M. Lorente, 2011, Oncogene.

The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway

B. Lutz, M. Sendtner, I. Galve-Roperh, 2015, Cell Death and Differentiation.

Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43

V. Casadó, E. Moreno, E. Canela, 2023, Neuropharmacology.

JunD is involved in the antiproliferative effect of Δ9-tetrahydrocannabinol on human breast cancer cells

M. Guzmán, G. Moreno-Bueno, J. Palacios, 2008, Oncogene.